Navigation Links
Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
Date:6/7/2009

Improvements in Systolic Blood Pressure and Triglycerides Also Observed

NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) today announced long-term, interim results from the DURATION-1 study that showed sustained glucose control with weight loss, as well as improvements in systolic blood pressure and triglycerides, through two years of treatment with exenatide once weekly, an investigational therapy for type 2 diabetes. These findings were presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans. A New Drug Application (NDA) for exenatide once weekly was recently submitted to the U.S. Food and Drug Administration.

In the controlled portion of the open-label study, patients received exenatide once weekly or BYETTA(R) (exenatide) injection for 30 weeks, followed by 74 weeks of treatment with exenatide once weekly for all patients during an open-ended assessment period. Significant reductions in A1C of 1.7 percent and fasting plasma glucose (FPG) of 40 mg/dL were maintained after two years of treatment. Sixty-five percent of patients achieved an A1C of 7 percent or less. A1C of less than 7 percent is the target for good glucose control as recommended by the ADA. Body weight was significantly reduced, with patients losing an average of 5.8 pounds. Serum lipid profiles were significantly improved, and there was a significant reduction in systolic blood pressure (SBP).

"These two-year DURATION-1 data showed that maintenance of steady state concentrations of exenatide may res
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
2. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
3. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
4. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
5. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
6. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
7. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
8. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire-FirstCall/--Orexigen®Therapeutics,Inc.(N...etreatmentofobesity,todayannouncedthatonNovember18...Directorsgrantedaninducementstockoptiontopurchase2...newlyappointedHeadoftheGlobalContraveProgram. ,...ontotheextentpermittedbylawandhasanexercisepricepe...
(Date:11/24/2009)...ire/--AFOXThanksgivingDaytelevisionspecialcalled"K...ewersthattheholidaysareatimetobegratefulformanydev...fightthatbattleeachdayassurvivors,caregivers,andad...turntotheiceofcancersurvivorsScottHamiltonandDorot...vidFosterwhowillperform"HopeisAlwaysHere,"asongwri...
(Date:11/24/2009).../PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGS...dcommercializingnovelpainmanagementtherapies,today...rectors,effectiveNovember19,2009.Mr.Orwinisa20-yea...ustryandhasbeeninstrumentalinthelaunchofseveralimp...sSeniorVicePresident,BioOncologyBusinessUnitatGene...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Is Smoking Tougher on Women 3F 60033 1Is Smoking Tougher on Women 3F 60033 2Is Smoking Tougher on Women 3F 60033 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 1Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 2Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 4Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 5Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 6Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 7BD Announces Agreement to Acquire HandyLab Inc 5669 1BD Announces Agreement to Acquire HandyLab Inc 5669 2BD Announces Agreement to Acquire HandyLab Inc 5669 3
...g review programs need more,money, WASHINGTON, Mar...ate by the Alzheimer,s Association shows that more...imer,s disease -- a 10,percent growth over previou...le in the coming decades unless new treatments and... , The new numbers re-emphasize the need for a str...
...ANBURY, N.J., March 21, 2007 /PRNewswire/ -- Amicu...ping small,molecule, orally-administered pharmacol...human genetic diseases, announced today,that it wi...leted,Phase 1 clinical studies of Plicera(TM) (iso...the of Medical Genetics (ACMG),Annual Meeting on M...
Other Medicine Technology:Alzheimer's Growth Shows Need for Increased FDA Funding 2Alzheimer's Growth Shows Need for Increased FDA Funding 3Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 2Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 3
(Date:11/24/2009)...,, SANCLEMENTE,Calif.,Nov.24/PRNewswire/--Biono...rchofnaturalremedies,announcedtodaytheavailability...olutionsforchildren,shealth.Atipsheeton"StayingNat...g"NaturalMoms"series,isnowavailableonthecompany,sw...gnuponthewebsiteforafreesubscriptiontotheNaturalMo...
(Date:11/24/2009)...cus on toys that pose choking hazard, are too loud...SDAY, Nov. 24 (HealthDay News) -- As the holiday s...any dangerous toys are still being sold in stores ...on of the 24th annual Trouble in Toyland report,...arch Group (PIRG). , The report focuses on toys...
(Date:11/24/2009)...November 18, 2009 - Oakland, Calif. A study condu...and scientists identifies a new class of therapeut...and possibly treat colon cancer, the third most de...al lipid molecules found in soy that research show... study, led by Julie Saba, MD, PhD, senior scienti...
(Date:11/24/2009)...,, New$2.0MillionAdBuyTargetingAK,AR,FL,IN,LA,...ire-USNewswire/-- InthewakeoftheSenate,svoteonSat...lusAssociationtodayannouncedanewadvertisingcampaig...rida,Indiana,Louisiana,Maine,Nebraska,NorthDakota,...stheCenterforMedicareandMedicaidServices(CMS)repor...
(Date:11/24/2009)...BEER-SHEVA, ISRAEL November 24, 2009 Researchers ...ng a new device that detects cancerous skin tumors...aked eye. , During initial testing, the OSPI ins...ealed new textures of lesions that have never been...were diagnosed with various skin lesions and were ...
Breaking Medicine News(10 mins):Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2
... SOUTH SAN FRANCISCO, Calif. and PT. RICHMOND, Cal...aq: TSPT ) today,announced the completion of its...e merger transaction, Novacea changed its name to ...der the new,symbol. The merger creates a late-stag...
...ONTO, Feb. 2 /PRNewswire-FirstCall/ - MDS Inc. (TS...cts and services to the global life-sciences marke...ittee of independent directors to support the Comp...s continuously reviews the performance of MDS, and...
...RON, Mass., Feb. 2 Texcel, a leading provider ...ring solutions, has selected Tiziani Whitmyre, Inc...ng services partner. , , Tiziani Whitmyre ( www....ology-based companies to build brands, generate sa...
... Gary Weinberger, MD, FACS to...e, FL has finished formulating and the testing of ...the World. The Cream is manufactured in Italy and ... that Paphos Skincare of Ft Lauderdale, FL has fin...
...bruary 2, 2009, Cambridge, UK ,Anyone with a swee...ad to negative consequences. The same can be said... as demonstrated in a new study of myelin, a prote...d efficient signal conduction. However, in severa...
...ng what to expect before and after procedure aids ...HealthDay News) -- With increasing numbers of baby...t surgery is becoming a reality for more Americans...nt physical therapy can make recovery faster and b...
Other Medicine News:Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 2Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 3Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 4Health News:MDS Announces Formation of Special Committee 2Health News:Texcel Selects Tiziani Whitmyre for Public Relations, Internet Marketing Services 2Health News:The Only 100% Biologically Pure Lycopene Cream in the World 2Health News:A Checklist for Joint Replacement Surgery 2
...igned with 96-well plates in mind, Pipetman Ultra ...biology applications: PCR* sequencing, immunology .... Used with Diamond Tips from Gilson's patented Ro...mance and assure productivity.,* PCR process is co...
...y to operate in a wide variety of applications. &b...• The manifold can be freely rotated against ...ys at an optimum angle towards the microtiter plat...he use of most common pipette tips, and provides a...
...ilton is precision, ergonomics, and value!, Comfo...ip, contoured handle , Finer control while pipetti...ss-free tip ejection with long, lever tip ejector ... and sterilization without the need for recalibrat...
...g series in colonies, rows, and microplatesthat is...pette is becoming an ever-increasing force. Ergono... reason that the Multichannel Research model was d...ipette provides effective, precise, and rapid proc...
Medicine Products: